US2009017532A1PendingUtilityA1
Vector
Est. expiryJun 4, 2017(expired)· nominal 20-yr term from priority
C12N 15/87C07K 14/485C07K 16/40A61P 35/00C07K 14/70532A61P 31/00C07K 2319/02C07K 2317/622C07K 2319/30C07K 2319/00C12N 2799/027A61P 43/00C07K 16/30
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A vector comprising a nucleotide sequence of interest (“NOI”) encoding a product of interest (“POI”) is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI to the tumor.
Claims
exact text as granted — not AI-modified1 . A vector comprising a nucleotide sequence coding for an antibody comprising 5T4 complementarity determining regions (CDRs) of the 5T4 ScFv antibody amino acid sequence encoded by SEQ ID NO:1 or CDRs of the 5T4 Sab antibody amino acid sequence encoded by SEQ ID NO:2.
2 . The vector according to claim 1 , wherein the antibody is a 5T4 Fab, 5T4 Fv or 5T4 scFc fragment.
3 . The vector according to claim 1 , wherein the antibody is a humanized antibody.
4 . The vector according to claim 1 , wherein the vector is capable of expressing the antibody in a mammalian cell.
5 . A vector comprising a nucleotide sequence coding for an antibody comprising 5T4 complementarity determining regions (CDRs) having the amino acid sequence of KASQSVSNDVA (SEQ ID NO:26), YTSSRYA (SEQ ID NO:27), QQDYNSPPT (SEQ ID NO:28), GYYMH (SEQ ID NO:29), RINPNNGVTLYNQKFKD (SEQ ID NO:30), and STMITNYVMDY (SEQ ID NO:31).
6 . The vector according to claim 5 , wherein the antibody is a 5T4 Fab, 5T4 Fv or 5T4 scFc fragment.
7 . The vector according to claim 5 , wherein the antibody is a humanized antibody.
8 . The vector according to claim 5 , wherein the vector is capable of expressing the antibody in a mammalian cell.Join the waitlist — get patent alerts
Track US2009017532A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.